SHEN Li | Intercontinental Information Sciences, Eli Lilly China

スポンサーリンク

概要

• SHEN Li Junの詳細を見る
• 同名の論文著者
• Intercontinental Information Sciences, Eli Lilly Chinaの論文著者

関連著者

• KIM Sung-Bae

  Department of Medicine, Asan Medical Center, University of Ulsan

• Chung Hyun

  Cancer Metastasis Research Center

• Kim Sung-bae

  Department Of Oncology Asan Medical Center University Of Ulsan College Of Medicine

• Pen Daniel

  Eli Lilly Lacmass

• Xu Binghe

  Department Of Medical Oncology Cancer Hospital Chinese Academy Of Medical Sciences And Peking Union

• JIANG Zefei

  Breast Cancer Department, 307 Hospital

• YU Shiying

  Cancer Center of Tongji Hospital, Huazhong University of Science and Technology

• FENG Jifeng

  Department of Oncology, Jiangsu Province Cancer Hospital

• MALZYNER Artur

  Department of Oncology, Hospital Brigadeiro

• DEL GIGLIO

  Department of Oncology, Faculdade de Medicina da Fundacao ABC

• SHEN Li

  Intercontinental Information Sciences, Eli Lilly China

• Feng Jifeng

  Department Of Oncology Jiangsu Province Cancer Hospital

• Malzyner Artur

  Department Of Oncology Hospital Brigadeiro

• Del Giglio

  Department Of Oncology Faculdade De Medicina Da Fundacao Abc

• Chung Hyun

  Cancer Metastasis Research Center Yonsei Cancer Center Yonsei University College Of Medicine

• Yu Shiying

  Cancer Center Of Tongji Hospital Huazhong University Of Science And Technology

• Shen Li

  Intercontinental Information Sciences Eli Lilly China

• Jiang Zefei

  Breast Cancer Department 307 Hospital

もっと見る 閉じる

著作論文

• Biweekly gemcitabine-paclitaxel, gemcitabine-carboplatin, or gemcitabine-cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure : a phase II randomized selection trial

スポンサーリンク